Search Results 171-180 of 15216 for desimone

  1. Ga-DOTATATE PET for Localization of Phosphaturic Mesenchymal Tumors in Patients with Tumor Induced Osteomalacia - Mayo Clinic

    This study aims to identify cases of FGF23-mediated oncogenic osteoomalacia in which the underlying phosphaturic mesenchymal has not been found and perform 68Ga ...

  2. Winter Blues Archives - Mayo Clinic News Network

  3. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery (DISCOVERY) - Mayo Clinic

    About this study. The purpose o fthis study. A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will ...

  4. Pulmonary Hypertension Association Registry - Mayo Clinic

    About this study. The PHAR is a multicenter, prospective registry of newly evaluated patients at PHCCs in the United States who have either PAH or CTEPH.

  5. A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0

    About this study. The purpose of this study is to determine if elevations in oxidative stress, as measured by oxidation-reduction potential (ORP), ...

  6. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...

  7. Publications - Eleanna O. De Filippis, M.D., Ph.D. - Mayo Clinic

    Arora A, Jack K, Kumar AV, Borad M, Girardo ME, De Filippis E, Yang P, Dinu V. Genome-Wide Association Study of Gallstone Disease Identifies Novel Candidate ...

  8. Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients with Relapsed or Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    Giving ixazomib with pomalidomide and dexamethasone may be an effective treatment for relapsed or relapsed/refractory multiple myeloma. Participation ...

  9. A Study of Patients Undergoing Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer to Evaluate Perioperative Circulating Tumor DNA as a Prognostic Biomarker - Mayo Clinic

    A Study of Patients Undergoing Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer to Evaluate Perioperative Circulating Tumor DNA as a Prognostic ...

  10. Publications

    Publications. Shanafelt TD, West CP, Sinsky C, Trockel M, Tutty M, Wang H, Carlasare LE, Dyrbye LN. Changes in Burnout and Satisfaction With Work-Life ...